Article
Therapeutic priority of the PI3K/AKT/mTOR pathway in small cell lung cancers as revealed by a comprehensive genomic analysis.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer - 1 Sept 2014
Umemura Shigeki, Mimaki Sachiyo, Makinoshima Hideki, Tada Satoshi, Ishii Genichiro, Ohmatsu Hironobu, Niho Seiji, Yoh Kiyotaka, Matsumoto Shingo, Takahashi Akiko, Morise Masahiro, Nakamura Yuka, Ochiai Atsushi, Nagai Kanji, Iwakawa Reika, Kohno Takashi, Yokota Jun, Ohe Yuichiro, Esumi Hiroyasu, Tsuchihara Katsuya, Goto Koichi
Abstract excerpt
INTRODUCTION: The information regarding therapeutically relevant genomic alterations in small cell lung cancer (SCLC) is not well developed. We analyzed the SCLC genome using an integrative approach to stratify the targetable alterations. METHODS: We performed whole exon sequencing (n = 51) and copy number analysis (n =47) on surgically resected tumors and matched normal tissue samples from treatment-naive...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
